Lv11
40 积分 2023-07-28 加入
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study
4小时前
待确认
Tumor Mutational Burden From Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma After Resection
18天前
已完结
Tumor Mutational Burden From Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma After Resection
25天前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
26天前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
26天前
已完结
Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3
1个月前
已关闭
Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancer
1个月前
已完结
Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis
1个月前
已完结
Impact of timing between neoadjuvant therapy and radical cystectomy on survival in muscle-invasive bladder cancer
1个月前
已完结
Impact of Initial Relative Dose Intensity on Tumor Response and Survival Outcomes in Enfortumab Vedotin Monotherapy for Previously Treated Advanced Urothelial Carcinoma: A Real-world Analysis From a Multicenter Study
1个月前
已完结
皖公网安备34019202002308
